Anterogen.Co.,Ltd. (KOSDAQ:065660)
South Korea flag South Korea · Delayed Price · Currency is KRW
26,950
+100 (0.37%)
Jul 17, 2025, 9:40 AM KST

Anterogen.Co.,Ltd. Revenue

Anterogen.Co.,Ltd. had revenue of 1.60B KRW in the quarter ending March 31, 2025, with 4.56% growth. This brings the company's revenue in the last twelve months to 7.00B, up 7.90% year-over-year. In the year 2024, Anterogen.Co.,Ltd. had annual revenue of 6.93B with 6.66% growth.

Revenue (ttm)
7.00B
Revenue Growth
+7.90%
P/S Ratio
38.37
Revenue / Employee
n/a
Employees
n/a
Market Cap
268.66B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20246.93B432.62M6.66%
Dec 31, 20236.50B-90.76M-1.38%
Dec 31, 20226.59B-1.53B-18.85%
Dec 31, 20218.12B3.97B95.64%
Dec 31, 20204.15B3.67M0.09%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics4,898.69B
Celltrion3,662.23B
ALTEOGEN151.65B
Yuhan2,114.76B
SK Biopharmaceuticals578.00B
HLB Co., Ltd.74.64B
PharmaResearch392.31B
LigaChem Biosciences146.42B
Revenue Rankings